Apogee Therapeutics Price Chart
Apogee Therapeutics Volume Chart
Apogee Therapeutics Market Segments
Regular Trading Hours
| Open | $134.76 |
|---|---|
| Close | $134.50 |
| Low | $134.50 |
| Low Change | -0.27 (-0.20%) |
| High | $134.76 |
| High Change | +0.00 (+0.00%) |
| Range | $0.27 |
| Volume | 129.214K |
| Dollar Volume | $17.38M |
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
| Open | $134.55 |
|---|---|
| Close | $134.56 |
| Low | $134.55 |
| Low Change | 0.00 (0.00%) |
| High | $134.59 |
| High Change | +0.04 (+0.03%) |
| Range | $0.04 |
| Volume | 109.697K |
| Dollar Volume | $14.76M |
Regular Trading Hours Yesterday
| Open | $134.75 |
|---|---|
| Close | $134.58 |
| Low | $134.56 |
| Low Change | -0.19 (-0.14%) |
| High | $134.75 |
| High Change | +0.00 (+0.00%) |
| Range | $0.19 |
| Volume | 663.619K |
| Dollar Volume | $89.31M |
Premarket Yesterday
| Open | $134.60 |
|---|---|
| Close | $134.67 |
| Low | $134.60 |
| Low Change | 0.00 (0.00%) |
| High | $134.67 |
| High Change | +0.07 (+0.05%) |
| Range | $0.07 |
| Volume | 1.174K |
| Dollar Volume | $158.10K |
Apogee Therapeutics News
2 months agoinvesting.comApogee Therapeutics, BitFuFu rise premarket; AbbVie gains after deal
- 2 months agoinvesting.com
AbbVie strikes $10.9 billion deal for Apogee Therapeutics
2 months agobarrons.comWhy AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics
- 2 months agoinvesting.com
Why is Apogee Therapeutics stock surging today?
- 2 months agobarrons.com
S&P 500 Futures Fall in Premarket Trading; Apogee Therapeutics, Fervo Energy Lead
- 2 months agobarrons.com
Apogee Therapeutics Stock Soars. It’s Being Bought by AbbVie for $10.9 Billion.
- 2 months agobarrons.com
Intel, Micron, SpaceX, Apogee Therapeutics, and More Stocks That Explain Today’s Market
- 3 months agoinvesting.com
Apogee Therapeutics secures $1.3 billion Blackstone financing deal, shares dive
- 3 months agoinvesting.com
Apogee Therapeutics shares jump on $1.3B Blackstone deal
- 5 months agoinvesting.com
Apogee Therapeutics stock jumps on positive trial data
Apogee Therapeutics Top Trades
Apogee Therapeutics's top trade so far today returned +0.00%, while the top short trade returned -0.20%.
Apogee Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $134.66 |
|---|---|
| 10 Day Moving Average (SMA10) | $134.41 |
| 20 Day Moving Average (SMA20) | $134.29 |
| 50 Day Moving Average (SMA50) | $121.37 |
| 100 Day Moving Average (SMA100) | $102.23 |
| 200 Day Moving Average (SMA200) | $86.13 |
Apogee Therapeutics Statistics
| Average Volume (30 Days) | 1.53M |
|---|---|
| P/E Ratio (Current) | -34.62 |
| EPS (Current) | -$3.89 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$243.96M |
| Cash Ratio | 2.81 |
| Current Ratio | 26.44 |
| Quick Ratio | 26.44 |
| Debt to Equity | 0.00 |
| Enterprise Value | $10.09B |
| EV to EBITDA | -31.32 |
| EV to Sales | — |
| Price to Book | 8.53 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.22% |
| Return on Equity | -0.25% |
Apogee Therapeutics Stock Splits
There has been 1 stock split for Apogee Therapeutics (APGE). The reverse stock split occured on January 8, 2008 and reduced the outstanding shares at a ratio of 50:1.
| Date | Type | Ratio |
|---|---|---|
| Jan 8, 2008 | Reverse | 50:1 |
Apogee Therapeutics Dividends
There have been no dividends for Apogee Therapeutics (APGE).